Lynn M. Pouliot
Molecular Biology · 2012
A researcher in the Science corpus: 1 paper; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 21 citations into it
- Oncology — 12 citations into it
Whom Lynn M. Pouliot trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from Lynn M. Pouliot's perspective
Ordered by how strongly the researchers Lynn M. Pouliot trusts endorse each paper. Same corpus, a different order for every researcher.
- The basics of epithelial-mesenchymal transition. (Journal of Clinical Investigation)
- The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs (Nature Cell Biology)
- Epithelial-mesenchymal transitions in development and disease. (Cell)
- Loss of Keap1 function activates Nrf2 and provides advantages for lung cancer cell growth. (Cancer Research)
- A chromatin-mediated reversible drug tolerant state in cancer cell subpopulations (Cell)
- MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN. (Cancer Research)
- The epithelial–mesenchymal transition: new insights in signaling, development, and disease (Journal of Cell Biology)
- EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer (Oncogene)
- microRNA functions. (Annual Review of Cell and Developmental Biology)
- Resistance to therapy caused by intragenic deletion in BRCA2 (Nature)